Biosimilars in Multiple Sclerosis: Are We Ready?
How biosimilars can increase access to biologics for patients with multiple sclerosis (MS).
Related Articles
Peripheral Arterial and Aortic Diseases: Primary Care
An up-to-date overview of the ESC’s 2024 guidance on peripheral arterial and aortic diseases, including comparison with NICE, ESVS, and UK screening guidance
“A huge disaster”: Marc Benioff hits back at Microsoft CEO Satya Nadella, claims customers don’t take Copilot seriously
Benioff fired the latest shot in an ongoing war of words over Microsoft’s Copilot service
Nokia suddenly has a growth story again – and it’s all about AI
AI data center investments in the UK and other countries could pay off handsomely for the Finnish vendor.
Some Raw Truths About Raw Milk
Despite the serious risks of drinking it, a growing movement — including the potential health secretary Robert F. Kennedy Jr. — claims it has benefits.…
Seeing the risks of letting optometrists do eyelid surgery
Over a dozen states let optometrists wield a scalpel on the eyelid, opening up patients to missed cancers, unsafe procedures and more.
US Army plans 460 mph speeding spy jet to launch drones at 41,000 feet
The UAV or drone will likely be integrated in the Bombardier G6500 AC aircraft.
This metaphorical cat is both dead and alive – and it will help quantum engineers detect computing errors
A team led by UNSW quantum engineers has created a “Schrödinger’s cat” – a famous quantum thought experiment – inside a silicon chip.
Obesity needs a new definition beyond BMI, health experts argue
Experts say clinical obesity is more than a high BMI and instead is a disease in which excess body fat harms tissues, organs or doing…
Annual U.S. Dementia Cases Projected to Rise to 1 Million by 2060
A new study finds that dementia cases will increase at a much higher rate than expected, with lifetime risk rising to 42 percent after age…
CNIO research identifies a key protein for ‘burning’ fat
Obesity, which affects 650 million people worldwide, influences the development of cardiometabolic diseases and increases the risk of cancer. Guadalupe Sabio, head of the Organ…